about
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewTuberculosis and trimethoprim-sulfamethoxazoleAntibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan AfricaTransient erythroid hypoplasia in a patient on long-term co-trimoxazole therapyTreatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesisStatistical metamodeling for revealing synergistic antimicrobial interactionsHigh-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activityEvaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics.Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal florasIntrarenal distribution of trimethoprim and sulfamethoxazole.Challenges of antibacterial discoveryPenetration of trimethoprim and sulphamethoxazole into the aqueous humour.Synergy of trimethoprim-sulfamethoxazoleThe association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim.Antifolate-induced depletion of intracellular glycine and purines inhibits thymineless death in E. coli.Trimethoprim and sulfonamide resistanceAntibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus's egg?A docking-based receptor library of antibiotics and its novel application in predicting chronic mixture toxicity for environmental risk assessment.Comparative pharmacokinetics of co-trifamole and co-trimoxazole to 'steady state' in normal subjectsReplacing sulfa drugs with novel DHPS inhibitorsEfficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis.Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazolePharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acidTreatment of uncomplicated urinary tract infections with trimethoprim versus sulfisoxazole, with special reference to antibody-coated bacteria and fecal flora.Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactionsComparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).Trimethoprim-sulfamethoxazole compared with sulfamethoxazole in urinary tract infection.Pharmacokinetics of trimethoprim-sulfamethoxazole in children.Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.Intrinsic and acquired resistance mechanisms in enterococcus.Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazoleIncidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.Horse erythrocyte factor enhancing sulphonamide activity. I. Partial purification and data on the mode of action.A Biotin Biosynthesis Gene Restricted to Helicobacter.Sensitivity of Nocardia to trimethoprim and sulphonamides in vitroSulphamethoxazole-trimethoprim: the first two yearsThe sensitivity of Pseudomonas pseudomallei to trimethoprim and sulphamethoxazole in vitroPoor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia
P2860
Q21133667-21217861-C199-4244-A7F2-7DFA5CF266C9Q24645397-82408D48-9103-4959-BEA9-567724279402Q28076750-30D4CB3F-3456-4970-9E92-1BAFD966D874Q28084902-935F2589-7499-4709-A3F1-ABEEF24737DCQ28363383-9D687680-974B-4A16-A7A3-33E6EFE26D8DQ28368185-ABE260EF-B64C-4D6F-8BD9-C518199AA7D9Q28476193-74AB3646-2B2F-4974-9F06-E88F66FC2ED6Q28480878-663B8FB0-6754-47D1-9FBA-56065B5472D6Q33723181-999CC0C5-5245-41C1-8126-C7492FE64D6FQ33724208-ADEA5FBC-38C6-4522-920B-2B5C73048737Q33725103-EDA67485-7379-4B97-BF8C-C40526095AFCQ33793074-2B369507-473F-4D03-A28A-0FB1D4FE7941Q33996691-7E055309-9E0B-4BF2-AF8C-878E9CC4D8E3Q33998386-750010CF-853E-4EF2-91D8-99588F945611Q34084924-4B7A0B8E-19A3-434E-839E-8E22F49D0FA4Q34154105-6B295B0C-FBE0-40BD-953B-E8E387A82950Q34309123-16135F9B-C0DF-40FB-AE91-03AC3EB85220Q34421193-1A755FD0-AFAA-40A6-90BD-66385D21586DQ34473515-437576F8-C6AA-4DD9-BDD1-5662759D1040Q34511883-769E152D-8629-4286-A4A9-4E3C80B2D6D3Q34823402-C5A43B68-147D-472B-ACA3-F84EF5B11D72Q35273921-AC52EBF5-CE52-46EA-AB15-4580C81959F7Q35568914-18D3F673-BC69-43ED-951F-51A3D73A4069Q35640897-F196D5E2-AA16-4629-85E5-8858D527473AQ35646944-105AE919-9068-47E3-8F93-917C06693030Q35669909-35528E75-11F7-4A30-B266-9A0BF03B76BFQ35690237-598AAFC9-5F93-45C0-AA0B-3B1F5DA6A58EQ35886304-AD24E47F-EC16-46B1-8373-781828C5BF04Q35938601-CB932370-A007-4801-8D90-261D50ECA0F7Q35958717-9C84E760-7C64-428B-A9BB-052893060336Q36097885-2EDEFD08-92FF-4095-B932-0E2124A1F5E7Q36362547-2F630ED0-E3EE-40D5-AF5C-0930CE1D54C4Q36479303-59B9A973-5431-4B06-A88A-5B6A8FD99DE4Q36517673-B49DE461-C12B-42FE-AF22-84D903EDA799Q36518959-414CE760-0067-40A0-BA88-3C2B4655FBA6Q36574275-E09F7620-04B2-4575-A7DA-6ADB7894C2C4Q36620455-C4F9E203-6559-43DB-AA7E-EAC5932F3B55Q36627889-E6A22F5A-CA44-422C-858D-08C11EF70D43Q36632778-405CEBE1-A6E0-49A2-984F-E64809186F08Q36714307-19EA0CC5-0955-4BB3-BF0F-67C7E6108D17
P2860
description
1968 nî lūn-bûn
@nan
1968 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
name
Trimethoprim, a sulphonamide potentiator
@ast
Trimethoprim, a sulphonamide potentiator
@en
Trimethoprim, a sulphonamide potentiator
@nl
type
label
Trimethoprim, a sulphonamide potentiator
@ast
Trimethoprim, a sulphonamide potentiator
@en
Trimethoprim, a sulphonamide potentiator
@nl
prefLabel
Trimethoprim, a sulphonamide potentiator
@ast
Trimethoprim, a sulphonamide potentiator
@en
Trimethoprim, a sulphonamide potentiator
@nl
P2860
P3181
P1476
Trimethoprim, a sulphonamide potentiator
@en
P2093
G H Hitchings
S R Bushby
P2860
P3181
P356
10.1111/J.1476-5381.1968.TB00475.X
P407
P577
1968-05-01T00:00:00Z